Remote functionalization of SCH 39166: Discovery of potent and selective benzazepine dopamine D1 receptor antagonists

被引:6
|
作者
Sasikumar, T. K. [1 ]
Burnett, Duane A. [1 ]
Greenlee, William J. [1 ]
Smith, Michelle [1 ]
Fawzi, Ahmad [1 ]
Zhang, Hongtao [1 ]
Lachowicz, Jean E. [1 ]
机构
[1] Merck Res Labs, Dept Med Chem & Metab Disorders, Kenilworth, NJ 07033 USA
关键词
SCH; 39166; Ecopipam; Benzazepine; Dopamine antagonist; Obesity; D1; SCH-39166; ANALOGS; BINDING; INVIVO;
D O I
10.1016/j.bmcl.2009.12.094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel benzazepine derived dopamine D-1 antagonists have been discovered. These compounds are highly potent at D1 and showed excellent selectivity over D-2 and D-4 receptors. SAR studies revealed that a variety of functional groups are tolerated on the D-ring of known tetracyclic benzazepine analog 2, SCH 39166, leading to compounds with nanomolar potency at D-1 and good selectivity over D-2-like receptors. Published by Elsevier Ltd.
引用
收藏
页码:832 / 835
页数:4
相关论文
共 50 条
  • [21] SELECTIVE D2 DOPAMINE RECEPTOR AGONISTS PREVENT CATALEPSY INDUCED BY SCH 23390, A SELECTIVE D1 ANTAGONIST
    MELLER, E
    KUGA, S
    FRIEDHOFF, AJ
    GOLDSTEIN, M
    LIFE SCIENCES, 1985, 36 (19) : 1857 - 1864
  • [22] LACK OF ACUTE ANTIPSYCHOTIC EFFECT OF SCH-23390, A SELECTIVE DOPAMINE D1 RECEPTOR ANTAGONIST
    GESSA, GI
    CANU, A
    DELZOMPO, M
    BURRAI, C
    SERRA, G
    LANCET, 1991, 337 (8745): : 854 - 855
  • [23] Acute deleterious effects of cocaine on cardiac conduction, hemodynamics, and ventricular fibrillation threshold:: Effects of interaction with a selective dopamine D1 antagonist SCH 39166
    Kanani, PM
    Guse, PA
    Smith, WM
    Barnett, A
    Ellinwood, EH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (01) : 42 - 48
  • [24] D(1)-RECEPTOR ANTAGONISTS - COMPARISON OF [H-3] SCH39166 TO [H-3] SCH23390
    ALBURGES, ME
    HUNT, ME
    MCQUADE, RD
    WAMSLEY, JK
    JOURNAL OF CHEMICAL NEUROANATOMY, 1992, 5 (05) : 357 - 366
  • [25] Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166)
    Chausmer, AL
    Smith, BJ
    Kelly, RY
    Griffiths, RR
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 (02): : 111 - 120
  • [26] (+/-)-(N-ALKYLAMINO)BENZAZEPINE ANALOGS - NOVEL DOPAMINE D-1 RECEPTOR ANTAGONISTS
    SHAH, JH
    IZENWASSER, S
    GETERDOUGLASS, B
    WITKIN, JM
    NEWMAN, AH
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (21) : 4284 - 4293
  • [27] Discovery of potent and selective isoxazoline antagonists of the vitronectin receptor
    Pitts, WJ
    Wityak, J
    Jetter, J
    Harlow, PP
    Corjay, MH
    Mousa, SA
    Wexler, RR
    Jadhav, PK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U886 - U886
  • [28] NNC-112, NNC-687 AND NNC-756, NEW SELECTIVE AND HIGHLY POTENT DOPAMINE D1 RECEPTOR ANTAGONISTS
    ANDERSEN, PH
    GRONVALD, FC
    HOHLWEG, R
    HANSEN, LB
    GUDDAL, E
    BRAESTRUP, C
    NIELSEN, EB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (01) : 45 - 52
  • [29] INVIVO BINDING OF SCH-39166 - A D-1 SELECTIVE ANTAGONIST
    MCQUADE, RD
    DUFFY, RA
    COFFIN, VL
    CHIPKIN, RE
    BARNETT, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 257 (01): : 42 - 49
  • [30] POTENT LIPOPHILIC SUBSTITUTED BENZAMIDE DRUGS ARE NOT SELECTIVE D-1 DOPAMINE RECEPTOR ANTAGONISTS IN THE RAT
    FLEMINGER, S
    VANDEWATERBEEMD, H
    RUPNIAK, NMJ
    REAVILL, C
    TESTA, B
    JENNER, P
    MARSDEN, CD
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (06) : 363 - 368